Matthew Perry's decess turns out to be a guilty plea for a drug dealer.
In a shocking turn of events, Jasveen Sangha, also known as the "Ketamine Queen," has agreed to plead guilty to federal charges for supplying the lethal dose of ketamine that led to the death of actor Matthew Perry in October 2023.
Sangha, who operated a drug business from her Los Angeles apartment, is accused of selling the lethal dose of ketamine to Perry shortly before his overdose. The charges against her include operating a drug house, multiple counts of ketamine distribution, and distribution resulting in death.
The guilty plea marks the conclusion of the federal investigation into Perry's death. Sangha, who led a lavish lifestyle funded by her drug sales and promoted herself as a celebrity drug dealer with high-quality products, may face decades in prison.
Perry, best known for his role in the popular TV series "Friends," died in October 2023. His cause of death has been linked to ketamine. It is believed that he obtained the drug from the black market.
Four others, including two doctors, an assistant, and a friend of Perry's, were also arrested in connection with Perry's death. All four individuals have already pleaded guilty to supplying Perry with ketamine.
It's important to note that ketamine, while sometimes used illegally as a club drug, has been used as a reliable anesthetic for decades and can be used to treat certain patients with treatment-resistant depression under specific conditions. However, its misuse can lead to fatal consequences, as seen in Perry's case.
Sangha's trial, which was initially set for September 2024, will not proceed due to her guilty plea. Sentences for the five individuals will be handed down in the coming months.
Perry had a history of publicly discussing his struggles with addiction. His death serves as a grim reminder of the dangers of substance abuse and the importance of seeking help.
References: [1] Federal Court Plea Agreements [2] Los Angeles Times [3] CNN [4] BBC News
This article is based on recent 2025 reports and official plea agreements linked to federal court proceedings.
